The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
26 10 2019
Historique:
received: 13 09 2019
revised: 20 10 2019
accepted: 23 10 2019
entrez: 14 11 2019
pubmed: 14 11 2019
medline: 2 10 2020
Statut: epublish

Résumé

The L-protein of vesicular stomatitis virus (VSV) is a single-chain multi-domain RNA-dependent RNA polymerase. Previously reported attempts of intramolecular insertions of fluorescent proteins into the L-protein resulted in temperature-sensitive and highly attenuated polymerase activity. Here, we describe a novel insertion site that was selected based on in silico prediction. Of five preselected locations, insertion of the fluorescent protein mCherry in the VSV polymerase between amino acids 1620 and 1621 preserved polymerase function even after extended passaging and showed only mild attenuation compared to wildtype VSV polymerase. High magnification fluorescence imaging revealed a corpuscular cytosolic pattern for the L-protein. To confirm that the insertion site tolerates inclusion of proteins others than mCherry, we cloned mWasabi into the same position in L, generating a VSV-LmWasabi, which was also functional. We also generated a functional dual-color-dual-insertion VSV construct with intramolecularly labeled P and L-proteins. Together, our data present an approach to tag VSV polymerase intramolecularly without perturbing enzymatic activity. This L fusion protein might enable future tracing studies to monitor intracellular location of the VSV transcription and replication machinery in real-time life-imaging studies.

Identifiants

pubmed: 31717818
pii: v11110989
doi: 10.3390/v11110989
pmc: PMC6893670
pii:
doi:

Substances chimiques

Viral Proteins 0
DNA-Directed RNA Polymerases EC 2.7.7.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Austrian Science Fund FWF
ID : P 28395
Pays : Austria

Références

J Mol Med (Berl). 2012 Aug;90(8):959-70
pubmed: 22286341
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Virology. 2001 Jan 20;279(2):414-21
pubmed: 11162797
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5952-7
pubmed: 15069200
J Virol. 2010 May;84(9):4826-31
pubmed: 20181705
J Virol. 2018 Oct 29;92(22):
pubmed: 30135126
Mol Biol Cell. 2016 Nov 7;27(22):3385-3394
pubmed: 27385332
J Virol. 2005 Nov;79(22):14330-8
pubmed: 16254367
Virology. 1984 Oct 15;138(1):1-15
pubmed: 6093352
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13910-3
pubmed: 10570172
J Virol. 2016 May 27;90(12):5847
pubmed: 27234347
Curr Top Microbiol Immunol. 2004;283:61-119
pubmed: 15298168
J Virol. 1999 Aug;73(8):6937-45
pubmed: 10400792
Proc Natl Acad Sci U S A. 1976 Feb;73(2):442-6
pubmed: 174107
Proc Natl Acad Sci U S A. 1976 May;73(5):1504-8
pubmed: 179088
J Virol Methods. 2006 Jul;135(1):91-101
pubmed: 16569439
Mol Ther Oncolytics. 2016 Sep 28;3:16021
pubmed: 27738655
MBio. 2018 Sep 4;9(5):
pubmed: 30181255
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Virol. 2010 Feb;84(3):1625-30
pubmed: 19906913
J Virol. 1996 Apr;70(4):2318-23
pubmed: 8642658
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20075-80
pubmed: 21041632
J Virol. 2006 Jul;80(13):6368-77
pubmed: 16775325
Bioinformatics. 2014 Jun 15;30(12):1771-3
pubmed: 24532726
J Virol. 2002 Jul;76(14):7322-8
pubmed: 12072530
PLoS One. 2013 Jul 02;8(7):e67902
pubmed: 23844123
Cell. 2015 Jul 16;162(2):314-327
pubmed: 26144317
J Virol. 2007 Dec;81(24):13649-58
pubmed: 17898047
Acta Crystallogr F Struct Biol Commun. 2016 Feb;72(Pt 2):72-95
pubmed: 26841758
Proteins. 2010 May 1;78(6):1503-19
pubmed: 20077569
J Virol. 2014 Dec;88(24):14458-66
pubmed: 25297996
PLoS Pathog. 2010 Jun 24;6(6):e1000958
pubmed: 20585632
J Virol. 2002 Aug;76(15):7642-50
pubmed: 12097578
Mol Cell. 2007 Jan 12;25(1):85-97
pubmed: 17218273
Gene. 1992 Dec 15;122(2):281-8
pubmed: 1336756
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Nucleic Acids Res. 2014 Jan;42(Database issue):D336-46
pubmed: 24271400
J Virol. 2009 Aug;83(16):7948-58
pubmed: 19494013
J Virol. 2009 Dec;83(23):12241-52
pubmed: 19793815

Auteurs

Emmanuel Heilmann (E)

Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Janine Kimpel (J)

Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Stephan Geley (S)

Division of Molecular Pathophysiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Andreas Naschberger (A)

Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Carles Urbiola (C)

Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Tobias Nolden (T)

ViraTherapeutics GmbH, 6020 Innsbruck, Austria.

Dorotheé von Laer (D)

Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Guido Wollmann (G)

Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH